Trending FOX BUSINESS News: Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says
Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says

The pause on Johnson & Johnson’s coronavirus vaccine research study, which is due to an adverse reaction by one of the participants, is “quite common” in vaccine clinical trials, Health and Human Services Secretary Alex Azar told “Varney & Co.” on Tuesday.
via FOX BUSINESS NEWS Markets
https://ift.tt/3nJKhVU
Trending FOX BUSINESS News: Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says
Reviewed by Blogger Tricks
on
October 14, 2020
Rating: